about
A crucial role for Fgfr2-IIIb signalling in epidermal development and hair follicle patterningSpirochete-platelet attachment and thrombocytopenia in murine relapsing fever borreliosis.Hemostasis in the mouse (Mus musculus): a review.Integrins in vascular development.Dual role of pericyte α6β1-integrin in tumour blood vessels.Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival.Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclastsThe endothelial transcription factor ERG promotes vascular stability and growth through Wnt/β-catenin signaling.Nanoparticle-mediated gene delivery to tumour neovasculature.Tumour-associated endothelial-FAK correlated with molecular sub-type and prognostic factors in invasive breast cancer.Integrins in angiogenesis: multitalented molecules in a balancing act.Integrins and angiogenesis: unlocking the route to gene therapy.Interleukin-6 Stimulates Defective Angiogenesis.Regulation of COX-2 mediated signaling by alpha3 type IV noncollagenous domain in tumor angiogenesis.Endothelial-cell FAK targeting sensitizes tumours to DNA-damaging therapy.alpha3beta1 Integrin is required for normal development of the epidermal basement membrane.alphavbeta3 integrin and angiogenesis: a moody integrin in a changing environment.The role of cell adhesion pathways in angiogenesis.Regulation of lymphatic-blood vessel separation by endothelial Rac1.Specific deletion of focal adhesion kinase suppresses tumor formation and blocks malignant progression.Suppression of TGFβ and Angiogenesis by Type VII Collagen in Cutaneous SCC.Focal Adhesion Kinase (FAK) tyrosine 397E mutation restores the vascular leakage defect in endothelium-specific FAK-kinase dead mice.αvβ3 Integrin and tumour blood vessels-learning from the past to shape the future.Molecular Pathways: Endothelial Cell FAK-A Target for Cancer Treatment.Dual-action combination therapy enhances angiogenesis while reducing tumor growth and spread.Exploring Novel Methods for Modulating Tumor Blood Vessels in Cancer Treatment.Acute depletion of endothelial β3-integrin transiently inhibits tumor growth and angiogenesis in mice.Generation of point-mutant FAK knockin mice.alpha3beta1 integrin-controlled Smad7 regulates reepithelialization during wound healing in mice.Therapeutic expression of the platelet-specific integrin, alphaIIbbeta3, in a murine model for Glanzmann thrombasthenia.Pancreatic stellate cells regulate blood vessel density in the stroma of pancreatic ductal adenocarcinoma.Desmosomal proteins, including desmoglein 3, serve as novel negative markers for epidermal stem cell-containing population of keratinocytes.Fascin 1 is dispensable for developmental and tumour angiogenesis.Multiple roles of integrin-α3 at the neuromuscular junction.Farnesyltransferase inhibitors target multiple endothelial cell functions in angiogenesis.Multiple organ engraftment by bone-marrow-derived myofibroblasts and fibroblasts in bone-marrow-transplanted mice.Genetic ablation of the alpha 6-integrin subunit in Tie1Cre mice enhances tumour angiogenesis.Accelerated re-epithelialization in beta3-integrin-deficient- mice is associated with enhanced TGF-beta1 signaling.Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors.Efficient, inducible Cre-recombinase activation in vascular endothelium.
P50
Q28508094-561C76AA-2B9A-4E22-B0EF-F5C8CC54A69EQ33348942-EE5AB6F7-EAC6-488E-A7FF-9174FBD31CF3Q33537935-92422E6E-CF0D-435A-A8CB-1D7C6E56290DQ33690797-045D7876-A731-4BC3-A9FA-2B5708A75BB3Q33743181-388113C0-DA06-4B41-AFB1-16B663143C2BQ33835366-29B1641B-7F44-4EBB-B042-ED7145298D04Q33939357-04837E74-773F-409C-AC8F-CA91A17F5B4DQ34939997-3B1C0F80-6F76-49B2-85F5-7F6C6057E3C0Q35043747-2CE71396-9296-47FC-8372-B932106CF18FQ35137962-421AF35A-52CB-4A58-8802-308EDF511319Q35299292-56DABB41-ADB7-4F3B-92C8-BA16B903A0B1Q35645483-06966E25-E15C-4627-B438-FBE2E67B1A28Q35923153-2CF253B2-5F72-44E5-AEC4-DCABAC2ADA8CQ35925032-3847294F-5CED-46DD-B3B2-9338E12BA86EQ35945233-3B656176-AF84-4E10-8C7E-DDB640E9033AQ36274145-96FC9227-28AD-426D-8176-241832BF5F9EQ37220625-50D334DD-245A-4504-B0EB-BB2C15AC290BQ37257956-EAADF79D-9DD3-40D3-93A8-FEF8F232F5FCQ37424531-970C23B2-2E45-417E-BEE3-53A5972344B4Q37712330-55F4FD97-38AE-4F39-89B1-EDE3C37E5407Q38383977-74292563-FEE2-432C-A552-8196571736C9Q38706013-2EB2F22A-AD00-4DBF-98E9-DF40CFE3EF4FQ38836139-B927D008-6DE4-430B-8984-2CF96DF653DEQ38854580-24C96CD4-01C1-436A-B61E-3A2E8F74CF3CQ38920450-8727139A-90E2-42FA-8A14-D2801C5EC1E5Q39003100-62998F27-9DAA-4999-A396-4E64614BCE9DQ39084614-CFD07CB6-0343-43A5-AB47-71ACBF727D00Q39125536-714AF932-30DE-4743-A7CA-0D6FE1078491Q41860571-37D0D8E2-AACF-4637-8BF2-56F8F5571AB6Q42109626-611FC62B-0A51-4376-8858-2CEA71EAA2BEQ42363356-7E7FA273-825F-4585-B704-37BBED532B28Q42447018-2E00E1DE-2992-4B10-9B23-A92B19FE0567Q42906224-CB3606A5-D664-49F4-9F7E-F5F7B7F57551Q43267167-6EE33FC7-B9E4-48A0-82B7-EF4474C1A967Q43893391-9F14F093-22E3-401A-8666-5907E16FB2B3Q44580904-FDDF47D7-2465-45CB-A518-754EEED74255Q44826585-B337CD94-8197-4764-8302-F027D803D4F7Q45227038-117F3878-EDBD-4033-A424-4E0BBEE78AF7Q46079015-80D04A27-0FE8-479E-B244-ABC631337050Q46767104-BBFD0892-09AF-4BAA-B900-847F1E1F4C3B
P50
description
researcher
@en
wetenschapper
@nl
name
K M Hodivala-Dilke
@en
K M Hodivala-Dilke
@nl
type
label
K M Hodivala-Dilke
@en
K M Hodivala-Dilke
@nl
prefLabel
K M Hodivala-Dilke
@en
K M Hodivala-Dilke
@nl
P108
P106
P31
P496
0000-0002-2859-749X